CollPlant Biotechnologies Ltd - Ordinary Shares New

NASDAQ:CLGN   3:32:03 PM EDT
20.05
+2.80 (+16.23%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)205.67M
Current PE42.11
Forward PE 77.12
2yr Forward PE 10.55
See more stats
Estimates Current Quarter
Revenue$0.25 Million
Adjusted EPS-$0.28
See more estimates
10-Day MA$17.69
50-Day MA$17.11
200-Day MAN/A
See more pivots

CollPlant Biotechnologies Ltd - Ordinary Shares New Stock, NASDAQ:CLGN

Weizmann Science Park, 4 Oppenheimer Street, Rehovot, Tel Aviv 7670104
Israel
Phone: +972.73.232.5600
Number of Employees: 52

Description

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. It's products include VergenixSTR, VergenixFG, and CollPlant Surgical Matrix. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.